• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基葡萄糖在犬类和人类体内的药代动力学。

Pharmacokinetics of glucosamine in the dog and in man.

作者信息

Setnikar I, Giacchetti C, Zanolo G

出版信息

Arzneimittelforschung. 1986 Apr;36(4):729-35.

PMID:3718596
Abstract

The pharmacokinetics, organ distribution, metabolism and excretion of glucosamine were studied in the dog giving uniformly labelled [14C]-glucosamine (sulfate), i.v. or orally, in single doses. Immediately after i.v. administration, the radioactivity in plasma is due to glucosamine, and freely diffuses into organs and tissues. This radioactivity disappears quickly from plasma (initial t1/2 = 13 min, terminal t1/2 = 118 min). After 30-60 min the radioactivity in plasma is no longer due to glucosamine, but is incorporated into alpha- and beta-globulins. The protein-incorporated radioactivity is found already 20-30 min after i.v. administration, reaches a peak after 8 h and then slowly disappears, with a t1/2 = 2.9 days. Of the administered radioactivity, more than 34% is excreted in the urine, mainly as glucosamine, and 1.7% is excreted in the feces. Radioactivity is excreted also as [14C]-CO2 in the expired air. The radioactivity, after i.v. administration, diffuses rapidly from blood into the body. Some organs show an active uptake of radioactivity, e.g. the liver and the kidney. Other tissues, such as the articular cartilage, also have an active uptake. In most other organs the radioactivity found can be explained by passive diffusion processes from plasma. After oral administration of a single dose of [14C]-glucosamine the radioactivity is quickly and almost completely absorbed from the gastrointestinal tract. The pattern of disappearance, metabolic transformation, tissue distribution and excretion of the radioactivity are consistent with those found after i.v. administration.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在犬类动物中,以单次静脉注射或口服的方式给予均匀标记的[14C]-氨基葡萄糖(硫酸盐),对其药代动力学、器官分布、代谢及排泄情况进行了研究。静脉注射后即刻,血浆中的放射性源于氨基葡萄糖,它可自由扩散至各器官和组织。此放射性在血浆中迅速消失(初始半衰期=13分钟,终末半衰期=118分钟)。30 - 60分钟后,血浆中的放射性不再源于氨基葡萄糖,而是结合到α-和β-球蛋白中。静脉注射后20 - 30分钟即可发现蛋白质结合的放射性,8小时后达到峰值,随后缓慢消失,半衰期为2.9天。给药的放射性中,超过34%经尿液排泄,主要形式为氨基葡萄糖,1.7%经粪便排泄。放射性也以[14C]-二氧化碳的形式经呼出气体排出。静脉注射后,放射性迅速从血液扩散至体内。一些器官表现出对放射性的主动摄取,如肝脏和肾脏。其他组织,如关节软骨,也有主动摄取。在大多数其他器官中发现的放射性可通过血浆的被动扩散过程来解释。单次口服[14C]-氨基葡萄糖后,放射性迅速且几乎完全从胃肠道吸收。放射性的消失模式、代谢转化、组织分布及排泄情况与静脉注射后所见一致。(摘要截选至250字)

相似文献

1
Pharmacokinetics of glucosamine in the dog and in man.氨基葡萄糖在犬类和人类体内的药代动力学。
Arzneimittelforschung. 1986 Apr;36(4):729-35.
2
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.硫酸氨基葡萄糖的吸收、分布、代谢及排泄。综述
Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105.
3
Pharmacokinetics of glucosamine in man.氨基葡萄糖在人体中的药代动力学。
Arzneimittelforschung. 1993 Oct;43(10):1109-13.
4
Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat.给大鼠单次静脉注射或口服[14C]葡萄糖胺后放射性的吸收、分布和排泄。
Pharmatherapeutica. 1984;3(8):538-50.
5
Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.米格列醇的药代动力学。对大鼠、狗和人给药后的吸收、分布、代谢及排泄。
Arzneimittelforschung. 1997 Jun;47(6):734-45.
6
Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.4-乙酰氨基苯乙酸的药代动力学。首次通讯:单次给予14C标记化合物后在小鼠、大鼠、狗和猴体内的吸收、分布、代谢及排泄情况
Arzneimittelforschung. 1990 Jul;40(7):800-5.
7
Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.大鼠单次给药后[14C]依巴斯汀的吸收、分布、代谢和排泄
Arzneimittelforschung. 1994 Apr;44(4):527-38.
8
Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.大鼠、犬和猴单次口服给予[羰基-14C]枸橼酸莫沙必利后的吸收、分布及排泄情况。
Arzneimittelforschung. 1993 Oct;43(10):1084-94.
9
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
10
Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.尼莫地平的药代动力学。I. 通讯:大鼠、狗和猴单次给予[14C]尼莫地平后的吸收、血浆浓度及排泄
Arzneimittelforschung. 1985;35(12):1781-6.

引用本文的文献

1
Biallelic loss-of-function variants result in impaired sulfate transport and skeletal phenotypes, including short stature, scoliosis, and skeletal dysplasia.双等位基因功能丧失变异导致硫酸盐转运受损和骨骼表型,包括身材矮小、脊柱侧弯和骨骼发育异常。
Genet Med Open. 2024 Dec 26;3:101958. doi: 10.1016/j.gimo.2024.101958. eCollection 2025.
2
Glucosamine Inhibits the Proliferation of Hepatocellular Carcinoma Cells by Eliciting Apoptosis, Autophagy, and the Anti-Warburg Effect.氨基葡萄糖通过引发细胞凋亡、自噬和抗瓦伯格效应来抑制肝癌细胞的增殖。
Scientifica (Cairo). 2025 Jan 8;2025:5685884. doi: 10.1155/sci5/5685884. eCollection 2025.
3
The repair of full-thickness articular cartilage defect using intra-articular administration of N-acetyl-D-glucosamine in the rabbit knee: randomized controlled trial.
兔膝关节内注射N-乙酰-D-葡萄糖胺修复全层关节软骨缺损:随机对照试验
Biomed Eng Online. 2015 Nov 18;14:105. doi: 10.1186/s12938-015-0100-y.
4
Effect of fucoidan extracted from mozuku on experimental cartilaginous tissue injury.昆布岩藻聚糖硫酸酯对实验性软骨组织损伤的影响。
Mar Drugs. 2012 Nov 13;10(11):2560-70. doi: 10.3390/md10112560.
5
A clinical study on glucosamine sulfate versus combination of glucosamine sulfate and NSAIDs in mild to moderate knee osteoarthritis.硫酸氨基葡萄糖与硫酸氨基葡萄糖联合非甾体抗炎药治疗轻至中度膝关节骨关节炎的临床研究
ScientificWorldJournal. 2012;2012:902676. doi: 10.1100/2012/902676. Epub 2012 Apr 1.
6
Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine.骨吸收和重塑在鼠胶原酶诱导的骨关节炎后氨基葡萄糖给药。
Arthritis Res Ther. 2011 Mar 16;13(2):R44. doi: 10.1186/ar3283.
7
Dietary glucosamine under question.膳食氨基葡萄糖受到质疑。
Glycobiology. 2009 Jun;19(6):564-7. doi: 10.1093/glycob/cwp014. Epub 2009 Mar 2.
8
Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.摄入硫酸葡萄糖胺后人体血清葡萄糖胺水平较低,相对于外周有效性的能力。
Ann Rheum Dis. 2006 Feb;65(2):222-6. doi: 10.1136/ard.2005.036368. Epub 2005 Aug 3.
9
Glucosamine therapy for treating osteoarthritis.用于治疗骨关节炎的葡萄糖胺疗法。
Cochrane Database Syst Rev. 2005 Apr 18;2005(2):CD002946. doi: 10.1002/14651858.CD002946.pub2.
10
The use of glucosamine therapy in osteoarthritis.氨基葡萄糖疗法在骨关节炎中的应用。
Curr Pain Headache Rep. 2004 Dec;8(6):507-11. doi: 10.1007/s11916-004-0074-0.